| Literature DB >> 32945230 |
Cláudia Martins1,2,3,4, Veeren M Chauhan3, Marco Araújo1,2, Amjad Abouselo3, Cristina C Barrias1,2, Jonathan W Aylott3, Bruno Sarmento1,2,5.
Abstract
Therapeutic and diagnostic payloads are usually associated with properties that compromise their efficacy, such as poor aqueous solubility, short half-life, low bioavailability, nonspecific accumulation and diverse side effects. Nanotechnological solutions have emerged to circumvent some of these drawbacks, augmenting therapeutic and/or diagnostic outcomes. Nanotechnology has benefited from the rise in polymer science research for the development of novel nanosystems for therapeutic and diagnostic purposes. Polymers are a widely used class of biomaterials, with a considerable number of regulatory approvals for application in clinics. In addition to their versatility in production and functionalization, several synthetic and natural polymers demonstrate biocompatible properties that dictate their successful biological performance. This article highlights the physicochemical characteristics of a variety of natural and synthetic biocompatible polymers, as well as their role in the manufacture of nanotechnology-based systems, state-of-art applications in disease treatment and diagnosis, and current challenges in finding a way to clinics.Entities:
Keywords: biocompatibility; diagnosis; nanotechnology; polymers; therapeutic delivery
Mesh:
Substances:
Year: 2020 PMID: 32945230 DOI: 10.2217/nnm-2020-0145
Source DB: PubMed Journal: Nanomedicine (Lond) ISSN: 1743-5889 Impact factor: 5.307